CoChat

Whole-tumour evaluation with MRI and radiomics features to predict the efficacy of S-1 for adjuvant chemotherapy in postoperative pancreatic cancer patients: a pilot study

Open access

The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.

Abstract

Background: Multiple guidelines for pancreatic ductal adenocarcinoma (PDAC) suggest that all stages of patients need to receive postoperative adjuvant chemotherapy. S-1 is a recently emerged oral antitumour agent recommended by the guidelines. However, which population would benefit from S-1 needs to be determined, and predictors of chemotherapy response are needed for personalized precision medicine. This pilot study aimed to initially identify whether whole-tumour evaluation with MRI and radiomics features could be used for predicting the efficacy of S-1 and to find potential predictors of the efficacy of S-1 as evidence to assist personalized precision treatment. Methods: Forty-six patients with PDAC (31 in the primary cohort and 15 in the validation cohort) who underwent curative resection and subsequently adjuvant chemotherapy with S-1 were included. Pre-operative abdominal contrast-enhanced MRI was performed, and radiomics features of the whole PDAC were extracted from the primary cohort. After univariable analysis and radiomics features selection, a multivariable Cox regression model for survival analysis was subsequently used to select statistically significant factors associated with postoperative disease-free survival (DFS). Predictive capacities of the factors were tested on the validation cohort by using Kaplan–Meier method. Results: Multivariable Cox regression analysis identified the probability of T 1 WI_NGTDM_Strength and tumour location as independent predictors of the efficacy of S-1 for adjuvant chemotherapy of PDAC (p = 0.005 and 0.013) in the primary cohort, with hazard ratios (HRs) of 0.289 and 0.293, respectively. Further survival analysis showed that patients in the low-T 1 WI_NGTDM_Strength group had shorter DFS (median = 5.1 m) than those in the high-T 1 WI_NGTDM_Strength group (median = 13.0 m) (p = 0.006), and patients with PDAC on the pancreatic head exhibited shorter DFS (median = 7.0 m) than patients with tumours in other locations (median = 20.0 m) (p = 0.016). In the validation cohort, the difference in DFS between patients with low-T 1 WI_NGTDM_Strength and high-T 1 WI_NGTDM_Strength and the difference between patients with PDAC on the pancreatic head and that in other locations were approved, with marginally significant (p = 0.073 and 0.050), respectively. Conclusions: Whole-tumour radiomics feature of T 1 WI_NGTDM_Strength and tumour location were potential predictors of the efficacy of S-1 and for the precision selection of S-1 as adjuvant chemotherapy regimen for PDAC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12880-021-00605-4

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Whole-tumour radiomics analysis. Tumour segmentation was performed semi-automatically and whole-tumour radiomics features were extracted from the PDAC area (yellow overlay)
Fig. 1 Whole-tumour radiomics analysis. Tumour segmentation was performed semi-automatically and whole-tumour radiomics features were extracted from the PDAC area (yellow overlay)CC BY · PubMed Central
Fig. 2 Survival analysis (DFS) for postoperative patients using adjuvant chemotherapy with S-1 in the primary cohort (K–M method). Grouping by T1WI_NGTDM_Strength (a) and tumour location (b) both prompted significantly different postoperative DFS between the respective subgroups
Fig. 2 Survival analysis (DFS) for postoperative patients using adjuvant chemotherapy with S-1 in the primary cohort (K–M method). Grouping by T1WI_NGTDM_Strength (a) and tumour location (b) both prompted significantly different postoperative DFS between the respective subgroupsCC BY · PubMed Central
Fig. 3 Survival analysis (DFS) for postoperative patients using adjuvant chemotherapy with S-1 in the validation cohort (K–M method). Grouping by T1WI_NGTDM_Strength (a) and tumour location (b) both prompted marginally different postoperative DFS between the respective subgroups
Fig. 3 Survival analysis (DFS) for postoperative patients using adjuvant chemotherapy with S-1 in the validation cohort (K–M method). Grouping by T1WI_NGTDM_Strength (a) and tumour location (b) both prompted marginally different postoperative DFS between the respective subgroupsCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Cited by

See all 13

Metadata

Authors
Liang, L., Ding, Y., Yu, Y., Liu, K., Rao, S., Ge, Y., & Zeng, M.
Affiliations
Shanghai Medical College of Fudan University (CN)
Corresponding author
Zeng, Mengsu
Venue
BMC Medical Imaging
Published
2021-04-26
Volume
21
Issue
1
Pages
75-75
ISSN
1471-2342 (ISSN-L)
OpenAlex
W3158457961
Cited by
13
References
44
Citations by year
2025: 2 · 2024: 2 · 2023: 5 · 2022: 3
FWCI
1.32
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Medical Imaging (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Special Program of Clinical Research in Health Industry, Shanghai Municipal Health Commission (201840343)
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › MRI in cancer diagnosis
Keywords
pancreatic ductal adenocarcinoma, S-1, adjuvant chemotherapy, radiomics, treatment response prediction, disease-free survival, T1-weighted imaging, tumor location, pancreatic head, precision medicine, prognostic factors, curative resection, contrast-enhanced MRI, tumor heterogeneity
MeSH terms
Analysis of Variance, Antimetabolites, Antineoplastic, Contrast Media, Drug Administration Schedule, Drug Combinations, Female, Tegafur, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Oxonic Acid, Pancreatic Neoplasms, Pilot Projects, Postoperative Care, Retrospective Studies, Survival Analysis, Treatment Outcome, Chemotherapy, Adjuvant, Disease-Free Survival, Carcinoma, Pancreatic Ductal, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Whole-tumour evaluation with MRI and radiomics features to predict the efficacy of S-1 for adjuvant chemotherapy in postoperative pancreatic cancer patients: a pilot study. https://app.cochat.ai/papers/10.1186/s12880-021-00605-4
The paper
Liang, L., Ding, Y., Yu, Y., Liu, K., Rao, S., Ge, Y., & Zeng, M. (2021). Whole-tumour evaluation with MRI and radiomics features to predict the efficacy of S-1 for adjuvant chemotherapy in postoperative pancreatic cancer patients: a pilot study. BMC Medical Imaging. https://doi.org/10.1186/s12880-021-00605-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.